FDA Updates Rules for Accessing Trial Drugs in Crises
Published Date: 11/17/2025
Notice
Summary
The FDA just released new, easy-to-understand rules about how patients can get access to experimental drugs when no other treatments work. This update affects doctors, drug makers, and patients by clarifying the process and replacing old guidance from 1998. The new rules are effective starting November 17, 2025, and aim to speed up access without extra costs or delays.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Final FDA Expanded Access Guidance
The FDA published final guidance titled "Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers" on November 17, 2025. It finalizes the November 2, 2022 draft and replaces the 2016/2017 guidance, clarifying how patients and doctors can pursue access to investigational drugs when no other treatments work and stating the guidance is deregulatory in nature.
Clarified Consent and Submission Steps
The final guidance includes additional clarifications related to informed consent and the process for submission of expanded access requests. Those clarifications were added between the November 2022 draft and this final guidance and take effect with the guidance announced on November 17, 2025.
Manufacturers Must Publish Access Policies
Under section 561A of the FD&C Act (as amended by the Cures Act) and FDARA, a manufacturer or distributor must make its expanded access policy readily available to the public (for example, by posting it on a website). The policy must be posted by the earlier of the first initiation of a phase 2 or phase 3 study for the drug or within 15 days after the drug receives a fast track, breakthrough, or regenerative advanced therapy designation.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12239 — Agency Information Collection Activities; Proposed Collection; Comment Request; Extralabel Drug Use in Animals
The FDA wants your thoughts on how they collect info about using drugs in animals in ways not originally approved (called extralabel use). This affects vets, farmers, and animal drug makers who report this info. You’ve got until August 17, 2026, to share your comments—no cost changes, just making sure the paperwork is clear and easy.
2026-12236 — SpecGx LLC; Withdrawal of Approval of Abbreviated New Drug Application for Methylphenidate Hydrochloride Extended-Release Tablets, 27 Milligrams, 36 Milligrams, and 54 Milligrams
SpecGx LLC has asked the FDA to withdraw its approval for three strengths (27 mg, 36 mg, and 54 mg) of its methylphenidate extended-release tablets, effective June 18, 2026. This means these specific versions of the medicine will no longer be allowed on the market. Patients and pharmacies using these doses should look for alternatives, but no extra costs or penalties are mentioned.
2026-12235 — Advisory Committee; Science Board to the Food and Drug Administration; Renewal
The FDA is renewing its Science Board for two more years, keeping expert advice flowing to help ensure safe and effective drugs and products. This renewal affects scientists and public health folks who guide the FDA’s big decisions, with the new term lasting until June 26, 2028. No extra costs or delays are expected—just more smart brains working for your health!
2026-12245 — Authorization of Emergency Use for Two Animal Drugs for the Prevention and Treatment of New World Screwworm; Availability
The FDA just gave the green light for two new animal drugs to fight the nasty New World screwworm, a bug that harms cattle, horses, pigs, and even exotic animals. These emergency approvals started in April 2026 to help protect U.S. livestock and wildlife quickly. Farmers, vets, and animal lovers can now use these treatments to stop infestations and keep animals safe without delay.
2026-12238 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements
The FDA is asking for public feedback by July 20, 2026, on their rules that keep dietary supplements safe and made right. These rules affect companies that make, package, label, or store supplements, helping ensure products are high quality without adding extra costs. This review keeps the safety standards up-to-date and clear for everyone involved.
2026-12237 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice Regulations for Type A Medicated Articles and Medicated Feeds
The FDA is updating how companies that make special animal medicines and feeds keep their records and follow quality rules. This affects manufacturers of Type A medicated articles and medicated feeds, helping ensure safe and reliable products for animals. Comments on these changes are open until July 20, 2026, and the updates aim to keep things clear without adding extra costs.
Previous / Next Documents
Previous: 2025-19981 — Notice of Proposed Subaward Under a Council-Selected Restoration Component Award
The Gulf Coast Ecosystem Restoration Council plans to give an extra $1.5 million to the Armand Bayou Nature Center to help buy and protect 106 acres of land in Texas. This change is part of a bigger $24.3 million Texas coastal conservation project. If you care about saving nature and coastal habitats, this is a big win coming soon!
Next: 2025-19985 — Agency Information Collection Activities; Proposed eCollection eComments Requested; Application and Permit To Import Firearms, Ammunition, and Defense Articles (ATF Form 5330.3B (“Form 6, Part II”))
The ATF is updating its form for importing guns, ammo, and defense gear and wants your feedback by December 17, 2025. This affects importers who’ll see clearer, easier ways to submit their paperwork, possibly online. The goal? Cut down on hassle and keep things running smoothly without extra costs or delays.